The The The

The 5 ASX stocks that will likely be supported vs the 17 facing headwinds

Equity 6 minutes to read
Jessica Amir

Australian Market Strategist

Summary:  What an important time of year. Not only is it end of half year in the US and End Of Financial Year in Australia, but the index and benchmark creator, S&P Dow Jones Indices is adding and removing stocks from key ASX indices ahead of June 20. So, we are sharing the five stocks that could likely to be supported, and the 17 stocks that could face headwinds after being removed from key indices.


As the news broke late Friday afternoon, that the S&P Dow Jones Indices quarterly rebalance was announced, we were quick to Tweet it. No surprises for guessing, the benchmark ASX200 index will be welcoming 4 mostly commodity companies who have been outperforming the market, while it is booting out 4 tech companies and one investment manager who’s shares have taken a slide as we nestle into higher for longer interest rates.

It’s important to note, the S&P Dow Jones Indices reveals which stocks it will add/remove from various key indices ahead of time, so investors, ETF providers and fund managers have a head start, before the changes take effect, before Monday 20 June. This means, if a stock is added to the index, ETF providers who copycat indices will typically be forced to compulsorily buy stocks being added and sell stocks being removed from key indices.

Simultaneity, it’s already a very busy time of year; Half Year rebalancing in the US, and End of Financial Year rebalancing in Australia, takes place prior to June 30. This is typically where we see investment managers bring their asset allocations back into alignment. This might mean fund managers trim profits from stocks and sectors that have done well. And they add to positions in those stocks and sectors that have underperformed year-on-year, to ensure their funds meet their set mandates.

However now, as 5 ASX stocks will be added and 17 will ousted from key indices before June 20 2022, it’s really important to note which stocks they are, as they may face bigger swings in there prices (due to S&P Rebalancing and EOFY).


In the ASX50

  • Mineral Resources (MIN) will be ADDED.

In the ASX50

  • Block (SQ2) will be REMOVED


In the ASX100

  •  Magellan Financial Group (MFG) will be REMOVED

In the ASX200


The following stocks will be ADDED

  • Brainchip (BRN)

  • Core Lithium (CXO)

  • Lake Resources (LKE) and

  • New Hope Corporation (NHC)

In the ASX200

The following stocks will be REMOVED:

  • Appen (APX)

  • Codan (CDN)

  • Polynovo (PNV)

  • PTM Platinum Asset Management (PTM)

  • Tyro Payments (TYR).


In the ASX Technology Index

The following will be REMOVED:

  • Adore Beauty Group (ABY)

  • Advanced Human Imaging (AHI)

  • Catapult Group (CAT)

  • International Limited (DW8)

  • Envirosuite (EVS)

  • Hipages Group Holdings (HPG)

  • Spenda (SPX)

  • Symbio Holdings (SYM)

  • Volpara Health Technologies (VHT)

  • Vection Technologies (VR1)

And lastly, as we previously alluded to in our story on how to pick stocks, don’t forget you can stay abreast of index rebalances by following news on your favourite indices here.


For daily commentary, follow our global teams insights here. 



Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo Capital Markets HK Limited holds a Type 1 Regulated Activity (Dealing in securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged foreign exchange trading); Type 4 Regulated Activity (Advising on securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong

By clicking on certain links on this site, you are aware and agree to leave the website of Saxo Capital Markets, proceed on to the linked site managed by Saxo Group and where you will be subject to the terms of that linked site.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

Please note that the information on this site and any product and services we offer are not targeted at investors residing in the United States and Japan, and are not intended for distribution to, or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Please click here to view our full disclaimer.